home / stock / soly / soly news

SOLY News and Press, Soliton Inc. From 07/23/19

Stock Information
Company Name: Soliton Inc.
Stock Symbol: SOLY
Market: NYSE
Website: soliton.com
Menu
SOLY SOLY Quote SOLY Short SOLY News SOLY Articles SOLY Message Board
Get SOLY Alerts

News, Short Squeeze, Breakout and More Instantly...
SOLY - Soliton's FDA Cleared Device is Granted Key Patent

HOUSTON , July 23, 2019 /PRNewswire/ -- Soliton, Inc., (Nasdaq: SOLY) ("Soliton" or the "Company"), a medical device company with a novel and proprietary platform technology licensed from The University of Texas on behalf of the MD Anderson Cancer Center ("MD Anderson"), today anno...
SOLY - Wall Street Breakfast: What Moved Markets This Week

Listen on the go! Subscribe now to receive Wall Street Breakfast by 8:00 a.m. every trading day, and by 10:00 a.m. every Saturday, on Seeking Alpha , iTunes , Stitcher and Spotify (click the highlighted links). Stocks faded into the close to finish lower Friday, capping t...

SOLY - Mnuchin Opens To Libra, Tesla Closes Above $250; Goldman Beats, Confirming Charts, Buy

While Mnuchin did his best to persuade that he is going to give Facebook a hard time, he did the opposite Facebook (FB) has the resources to overcome any regulatory issues that exist. Mnuchin states that Libra must prove that it conforms to AML (Anti-Money Laundering) and Know-Your-Customer....

SOLY - Soliton Announces Submission for IRB Approval of Pivotal Cellulite Trial Protocol

HOUSTON , July 16, 2019 /PRNewswire/ -- Soliton, Inc., (Nasdaq: SOLY) ("Soliton" or the "Company"), a medical device company with a novel and proprietary platform technology licensed from The University of Texas on behalf of the MD Anderson Cancer Center ("MD Anderson"), today anno...
SOLY - CIR, CPE and GLPG among midday movers

Gainers:  Capricor Therapeutics (NASDAQ: CAPR ) +148% . Carolina Trust BancShares (NASDAQ: CART ) +30% . SSLJ.com Limited (YGTY) +29% . Chicken Soup for the Soul Entertainment (NASDAQ: CSSE ) +22% . AVROBIO (NASDAQ: AVRO ) +22% . Mereo BioPharma Group (NASDAQ: MREO ) +21% . Amer...

SOLY - Soliton Announces Positive 26-week Cellulite Clinical Trial Results Demonstrate Long-Term Improvement

HOUSTON , July 15, 2019 /PRNewswire/ -- Soliton, Inc., (Nasdaq: SOLY) ("Soliton" or the "Company"), a medical device company with a novel and proprietary platform technology licensed from The University of Texas on behalf of the MD Anderson Cancer Center ("MD Anderson"), today anno...

SOLY - AIR, CI and OMCL among midday movers

Gainers:  Immunic (NASDAQ: IMUX ) +48% . Soliton (NASDAQ: SOLY ) +17% . Biomerica (NASDAQ: BMRA ) +14% . Foresight Autonomous Holdings (NASDAQ: FRSX ) +13% . Cemtrex (NASDAQ: CETX ) +12% . Verastem (NASDAQ: VSTM ) +11% . Cigna Corporation (NYSE: CI ) +11% . Mastech Digital (NYS...
SOLY - Soliton Expands Clinical Trial Sites to include SkinCare Physicians

HOUSTON , July 10, 2019 /PRNewswire/ -- Soliton, Inc. (Nasdaq: SOLY) ("Soliton" or the "Company"), a medical device company with a novel and proprietary platform technology licensed from The University of Texas on behalf of the MD Anderson Cancer Center ("MD Anderson"), today annou...

SOLY - Soliton up 25% ahead of shockwave data in cellulite

Soliton ( SOLY +25% ) is up on 34% higher volume in apparent response to its announcement that will will release cumulative 26-week patient data from its proof-of-concept study of its acoustic shockwave device for the potential treatment of moderate-to-severe cellulite on Monday, July 15...

SOLY - Soliton to Announce Cellulite Trial Data for 26-Week Period on July 15, 2019

HOUSTON , July 8, 2019 /PRNewswire/ -- Soliton, Inc., (NASDAQ: SOLY) ("Soliton" or the "Company"), a medical device company with a novel and proprietary platform technology licensed from The University of Texas on behalf of the MD Anderson Cancer Center ("MD Anderson"), today announced ...
Previous 10 Next 10